<DOC>
	<DOC>NCT02750605</DOC>
	<brief_summary>The purpose of this trial is to compare short- medium long-term results in treatment of PAD (peripheral arterial disease) in the crural arteries with either drug coated balloon or conventional balloons in a prospective , randomized, single center study Results will be defined as: Limb salvage, Event-free survival, Freedom from TLR (target lesion revascularization), Primary patency, Clinical success, Serious adverse events, and the patients will be followed-up for 1 years. Primary endpoints: Primary Patency at 12 months Secondary endpoints: Event free survival, Clinical success at 6,12 months, Technical success, Serious adverse events, TLR (clinical driven),</brief_summary>
	<brief_title>DEB ( Drug Eluting Balloon) in Crural Arteries and Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Critical limb ischemia. Rutherford class 46 Crural disease, long lesions, more than 2 cm. Life expectancy &gt; 1year &gt; 18 years Pregnancy Patients disapproval Allergy to drug or contrast</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>